A Comparative Clinical Trial On The Efficacy Of Vidangadi Loha And Phalatrikadi Ghanavati With And Without The Prior Administration Of Virechana Karma In Madhumeha (Obese Diabetic).

ALL INDIA INSTITUTE OF AYURVEDA0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1.Patients of either gender in the age group of 30-60 years.
•2.Patients with classical signs and symptoms of Madhumeha.
•3.Patients giving the clinical history of Obese Diabetic (DM Type II).
•4.Patients with random blood sugar level (RBS) >200 mg/dl up to 350 mg/dl
•5.Fasting blood sugar (FBS) >126 mg/dl up to 250 mg/dl
•6.Postprandial blood sugar (PPBS) >140 mg/dl up to 350 mg/dl
•7.Glycosylated haemoglobin > 7.5% up to 15%
•NOTE (In the above-given criteria, there is one should be present and raised HbA1C is necessary.)
•8.Sthula Pramehi (Overweight / Obese - BMI >25 g/m2)
•9.Newly /early diagnosed cases to be included as per following criteria:
•i.Patients who are not taking any conventional medicine for more than 3 months, whose sugar levels are raised and fall within the inclusive criteria mentioned above and are willing to take Ayurvedic treatment.
•ii.Patient accidently diagnosed in routine check-up or when appeared with other complaints in the hospital.
•iii.Early diagnosed diabetic patients (Maximum 3 years of diabetic history) and not taking any pharmacological drugs since last 3 months.

•1.Patients having insulin dependent DM (type 1) and receiving insulin / OHA
•2.Excessive blood glucose: FBS > 250 mg/dl, PPBS > 350 mg/dl, RBS >350 mg/dl and HbA1c >15%
•3.Emergency conditions in cases of DM.
•4.Patients with acute/chronic liver disease with elevated liver enzymes.
•5.Chronic complications like microvascular and macrovascular derangements.
•6.Patients reporting to be hypersensitive to any of the proposed trial drugs.
•7.Pregnant women/ lactating mothers
•8.Participation in other clinical studies in past 12 weeks.
•9.Takes psychotropic medications that raise blood glucose (e.g. atypical antipsychotics)

发起方